WT1 and gonadoblastoma: In summary, pathogenic variants in the WT1 gene, associated with multiple organ manifestations, require an interdisciplinary approach that includes early diagnosis together with genetic testing, individualization of treatment based on the clinical profile of the patient, and monitoring and early detection of tumors such as Wilms’ tumor and gonadoblastoma.